{"name": "SpingLeaf Therapeutics",
 "permalink": "spingleaf-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/spingleaf-therapeutics",
 "homepage_url": "http://www.springleaftx.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@springleaftx.com",
 "phone_number": "617.358.4927",
 "description": "",
 "created_at": "Fri May 13 03:03:52 UTC 2011",
 "updated_at": "Fri May 13 03:03:51 UTC 2011",
 "overview": "\u003Cp\u003ESpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf\u00e2\u20ac\u2122s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics. SpringLeaf was founded based on breakthrough science at MIT and is backed by leading investors including SR One, Flybridge Capital Partners and North Bridge Venture Partners.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       30],
      "assets/images/resized/0013/4434/134434v1-max-150x150.jpg"],
     [[250,
       51],
      "assets/images/resized/0013/4434/134434v1-max-250x250.jpg"],
     [[293,
       60],
      "assets/images/resized/0013/4434/134434v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Frank",
      "last_name": "Bobe",
      "permalink": "frank-bobe",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$15M",
 "funding_rounds":
  [{"round_code": "b",
    "source_url": "http://www.fiercebiotech.com/story/gsk-venture-group-backs-springleaf-15m-round/2011-05-11?utm_medium=rss\u0026utm_source=rss",
    "source_description": "GSK venture group backs SpringLeaf in $15M round",
    "raised_amount": 15000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 5,
    "funded_day": 12,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "GSK Venture Fund",
         "permalink": "gsk-venture-fund",
         "image": null},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "8 St. Mary's Street",
    "address2": "Suite 601",
    "zip_code": "02215",
    "city": "Boston",
    "state_code": "MA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}